Table 1 Characteristics and clinicopathological features of patients with endometrial cancer per LSR expression
Characteristics | Low-LSR | High-LSR | p value |
|---|---|---|---|
Number of cases | 75 | 153 | Â |
Age, years | 57 (52–66) | 62 (53–69) | 0.15 |
BMI | 21.8 (19.6–25.1) | 22.0 (19.6–25.1) | 0.77 |
Histological subtype | Â | Â | 0.061 |
  Endometrioid, Grade 1 | 26 (34.7) | 40 (26.1) |  |
  Endometrioid, Grade 2 | 20 (26.7) | 44 (28.8) |  |
  Endometrioid, Grade 3 | 22 (29.3) | 34 (22.2) |  |
  Serous | 7 (9.3) | 35 (22.9) |  |
FIGO stage | Â | Â | 0.045 |
  I–II | 57 (76.0) | 96 (62.7) |  |
  III–IV | 18 (24.0) | 57 (37.3) |  |
Depth of myometrial invasion | Â | Â | Â |
   ≥ 50% of myometrium | 29 (38.7) | 73 (47.7) | 0.20 |
   ≥ 75% of myometrium | 18 (24.0) | 57 (37.3) | 0.045 |
Tumor involvement of adnexa or serosa | 5 (6.7) | 41 (26.8) | 0.0002 |
LVSI | 32 (42.7) | 74 (48.4) | 0.48 |
Lymph node metastasis | 14 (18.7) | 37 (24.2) | 0.40 |
Distant metastasis | 1 (1.3) | 21 (13.7) | 0.0016 |